rs121918263
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001371279.1(REEP1):c.337C>T(p.Arg113*) variant causes a stop gained change. The variant allele was found at a frequency of 0.00000137 in 1,461,788 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001371279.1 stop_gained
Scores
Clinical Significance
Conservation
Publications
- hereditary spastic paraplegia 31Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
- neuronopathy, distal hereditary motor, type 5BInheritance: AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- neuronopathy, distal hereditary motor, type 5AInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- spinal muscular atrophy, distal, autosomal recessive, 6Inheritance: AR Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| REEP1 | NM_001371279.1 | c.337C>T | p.Arg113* | stop_gained | Exon 5 of 9 | ENST00000538924.7 | NP_001358208.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| REEP1 | ENST00000538924.7 | c.337C>T | p.Arg113* | stop_gained | Exon 5 of 9 | 5 | NM_001371279.1 | ENSP00000438346.3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461788Hom.: 0 Cov.: 32 AF XY: 0.00000275 AC XY: 2AN XY: 727208 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Hereditary spastic paraplegia 31 Pathogenic:5
- -
This sequence change creates a premature translational stop signal (p.Arg113*) in the REEP1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in REEP1 are known to be pathogenic (PMID: 18321925, 18644145, 32655478). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individuals with hereditary spastic paraplegia (PMID: 19034539, 23400676, 29629531). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 1863). For these reasons, this variant has been classified as Pathogenic. -
The stop gained c.337C>T (p.Arg113Ter) variant in REEP1 gene has been observed in heterozygous state in multiple individuals with hereditary spastic paraplegia (Park et. al., 2018; Loureiro et. al., 2013; Hewamadduma et. al., 2009). It has also been observed to segregate with disease in related individuals. The p.Arg113Ter variant is absent in gnomAD exomes database. This variant has been submitted to the ClinVar database as Pathogenic (multiple submitters). Computational evidence (MutationTaster - disease causing) predict a damaging effect on protein structure and function for this variant. The reference amino acid at this position on REEP1 gene is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. This sequence change creates a premature translational stop signal (p.Arg113*) in the REEP1 gene. It is expected to result in an absent or disrupted protein product. Loss-offunction variants in REEP1 are known to be pathogenic (Beetz C,et. al., 2012). For these reasons, this variant has been classified as Pathogenic. -
- -
- -
not provided Pathogenic:2
This variant has not been reported in large, multi-ethnic general populations. (http://gnomad.broadinstitute.org) This variant has been identified individuals with clinical features of hereditary spastic paraplegia and associates with disease in multiple families. This variant is not expected to cause loss of protein expression through nonsense-mediated decay. However, it disrupts a substantial portion of the protein, and therefore, is expected to disrupt its function. Assessment of experimental evidence suggests this variant results in abnormal protein function. (PMID: 20200447) -
Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 22703882, 21618648, 24221643, 25525159, 19034539, 30637453, 23400676, 28003645, 27549087, 24098485, 12634509, 29629531, 33866115, 35297556, 35132160, 31913854, 20200447) -
Hereditary spastic paraplegia Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at